NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.520
-0.060 (-2.33%)
At close: Aug 28, 2025, 4:00 PM
2.502
-0.018 (-0.72%)
After-hours: Aug 28, 2025, 4:03 PM EDT
NRx Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts that cover NRx Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $29.25, which forecasts a 1,060.71% increase in the stock price over the next year. The lowest target is $18 and the highest is $46.
Price Target: $29.25 (+1,060.71%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NRx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 → $34 | Strong Buy | Maintains | $31 → $34 | +1,249.21% | Aug 22, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +1,130.16% | Aug 19, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +1,130.16% | Aug 11, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +1,130.16% | Aug 4, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +1,130.16% | Jun 23, 2025 |
Financial Forecast
Revenue This Year
33.15M
Revenue Next Year
109.78M
from 33.15M
Increased by 231.16%
EPS This Year
-0.18
from -2.36
EPS Next Year
1.04
from -0.18
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.8M | 189.3M | |||
| Avg | 33.2M | 109.8M | |||
| Low | 29.4M | 41.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 471.0% | |||
| Avg | - | 231.2% | |||
| Low | - | 25.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.04 | 1.62 | |
| Avg | -0.18 | 1.04 | |
| Low | -0.39 | 0.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.